OATS or OCA for knee cartilage repairOATS transplants the patient's own cartilage-and-bone plugs for knee defects up to roughly 2 cm² whilst OCA uses shaped donor tissue for larger repairs, but prior failed surgery or subchondral bone loss shifts the choice to OCA regardless of size.OATS transplants the patient's own cartilage-and-bone plugs for knee defects up to roughly 2 cm² whilst OCA uses shaped donor tissue for larger repairs, but prior failed surgery or subchondral bone loss shifts the choice to OCA regardless of size.
ChondroFiller injection cost in the UKChondroFiller costs £3,000–£8,000 in the UK, with price determined entirely by defect size; the number of implant boxes required is confirmed only after imaging review.ChondroFiller costs £3,000–£8,000 in the UK, with price determined entirely by defect size; the number of implant boxes required is confirmed only after imaging review.
What IKDC and MOCART data show about ChondroFillerChondroFiller injection improves knee function by an average of 30 points on the IKDC scale — double the clinically meaningful threshold — across independent studies, though evidence derives from small cohorts of younger patients with focal cartilage defects.ChondroFiller injection improves knee function by an average of 30 points on the IKDC scale — double the clinically meaningful threshold — across independent studies, though evidence derives from small cohorts of younger patients with focal cartilage defects.
ACI versus MACI for knee cartilage repairCartilage defect size on MRI drives the choice between single-stage repair (AMIC, OATS) and two-stage cell therapy (MACI): below 2–4 cm², simpler alternatives often provide comparable results; at 3 cm² or larger, MACI demonstrates superiority.Cartilage defect size on MRI drives the choice between single-stage repair (AMIC, OATS) and two-stage cell therapy (MACI): below 2–4 cm², simpler alternatives often provide comparable results; at 3 cm² or larger, MACI demonstrates superiority.
Questions to ask before a ChondroFiller injectionChondroFiller is a Type I collagen hydrogel injected into the joint where it recruits the patient's own progenitor cells to repair cartilage over months rather than days. Specific suitability criteria apply; questions a patient asks beforehand substantially influence whether expectations align with realistic outcomes.ChondroFiller is a Type I collagen hydrogel injected into the joint where it recruits the patient's own progenitor cells to repair cartilage over months rather than days. Specific suitability criteria apply; questions a patient asks beforehand substantially influence whether expectations align with realistic outcomes.
Knee cartilage damage symptoms and who to seeArticular cartilage lacks a blood supply and cannot repair itself; untreated defects larger than 1 cm risk progressive worsening and osteoarthritis.Articular cartilage lacks a blood supply and cannot repair itself; untreated defects larger than 1 cm risk progressive worsening and osteoarthritis.
ChondroFiller repeat injections and long-term repairChondroFiller recruits the patient's progenitor cells into a collagen scaffold that degrades over 12–18 months whilst repair tissue develops; 81% of hip patients achieved good or excellent outcomes at three to five years, but success depends heavily on whether osteoarthritis is early-stage or advanced.ChondroFiller recruits the patient's progenitor cells into a collagen scaffold that degrades over 12–18 months whilst repair tissue develops; 81% of hip patients achieved good or excellent outcomes at three to five years, but success depends heavily on whether osteoarthritis is early-stage or advanced.
AMIC versus ACI for knee cartilage repairAMIC completes knee cartilage repair in a single operation using bone-marrow stem cells held by a collagen scaffold; ACI requires two procedures to culture and reimplant the patient's own cartilage cells. A 2024 meta-analysis found outcomes between the two approaches broadly equivalent.AMIC completes knee cartilage repair in a single operation using bone-marrow stem cells held by a collagen scaffold; ACI requires two procedures to culture and reimplant the patient's own cartilage cells. A 2024 meta-analysis found outcomes between the two approaches broadly equivalent.
ChondroFiller injection for talar dome cartilage defectsChondroFiller is an ultrasound-guided collagen scaffold injection that recruits the patient's own progenitor cells to repair talar cartilage defects over 12–24 months, positioned for lesions exceeding 15 mm that fail conservative care.ChondroFiller is an ultrasound-guided collagen scaffold injection that recruits the patient's own progenitor cells to repair talar cartilage defects over 12–24 months, positioned for lesions exceeding 15 mm that fail conservative care.
Knee Cartilage Repair and PreservationArticular cartilage lacks blood vessels, so when damaged it forms fibrocartilage—a mechanically inferior scar tissue that typically deteriorates within two to three years. This biological constraint shapes every treatment option, from temporary symptom relief to procedures attempting true cartilage regeneration.Articular cartilage lacks blood vessels, so when damaged it forms fibrocartilage—a mechanically inferior scar tissue that typically deteriorates within two to three years. This biological constraint shapes every treatment option, from temporary symptom relief to procedures attempting true cartilage regeneration.
Choosing a UK ChondroFiller providerChondroFiller is a collagen scaffold injected under ultrasound guidance that recruits the patient's own repair cells into focal cartilage defects. It does not work for diffuse osteoarthritis, which requires surgical escalation instead.ChondroFiller is a collagen scaffold injected under ultrasound guidance that recruits the patient's own repair cells into focal cartilage defects. It does not work for diffuse osteoarthritis, which requires surgical escalation instead.
When cartilage repair is the right choiceCartilage repair is suited to younger, active patients with isolated damage in otherwise healthy joints where conservative care has not worked. It is mechanistically impossible when underlying bone is worn smooth, degeneration spans multiple compartments, or malalignment and instability persist uncorrected.Cartilage repair is suited to younger, active patients with isolated damage in otherwise healthy joints where conservative care has not worked. It is mechanistically impossible when underlying bone is worn smooth, degeneration spans multiple compartments, or malalignment and instability persist uncorrected.